Chargement en cours...
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Russo |
| Publié: |
"Consilium Medicum" Publishing house
2013-01-01
|
| Collection: | Терапевтический архив |
| Sujets: | |
| Accès en ligne: | https://ter-arkhiv.ru/0040-3660/article/view/31226 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|